Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00947219Not ApplicableCompleted

Treatment of Androgenic Alopecia in Males

Role: lead

NCT01016964Not ApplicableCompleted

Treatment of Androgenetic Alopecia in Females, 12 Beam

Role: lead

NCT00981461Not ApplicableCompleted

Treatment of Androgenetic Alopecia in Females, 9 Beam

Role: lead

NCT00947505Not ApplicableCompleted

Treatment of Androgenetic Alopecia in Males

Role: lead

NCT00830908Not ApplicableCompleted

HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis

Role: lead

All 5 trials loaded